CARIS MPI, INC.

BRCANSWERS

BRCA ANSWERS;BRC ANSWERS;Medical testing for diagnostic or treatment purposes in the field of cancer;

C.O.D.E.

CODE;Healthcare and medical services, namely, providing a database in the field of molecular profiling to allow users to acquire, utilize, access, or share molecular tumor profiling derived information including clinical outcome within a collaborative, secured environment all for treatment and diagnostic purposes;Research services, namely, providing a database in the field of molecular profiling to allow users to acquire, utilize, access, or share molecular tumor profiling derived information including clinical outcome within a collaborative, secured environment all for scientific research purposes;

CARIS ASSURE

Medical screening services in the field of cancer; medical diagnostic testing, monitoring and reporting services in the field of cancer; pathology diagnostic services for medical purposes in the field of cancer; prognostic analysis services for medical purposes; theranostic analysis services for medical purposes; molecular diagnostic services for medical purposes;Medical research, namely, assessment of clinical data; Medical research, namely, assessment of molecular profiling data, clinical data, and outcomes data to better understand cancer and treatment thereof;

CARIS BIOREPOSITORY

diagnostic testing of human specimens for medical purposes, namely, medical diagnostic monitoring, testing and reporting services and molecular diagnostic testing services;BIOREPOSITORY;

CARIS DIAGNOSTICS

The mark consists of the wording CARIS DIAGNOSTICS in stylized font underneath three arched, half-concentric, curved lines. The wording CARIS is over the wording DIAGNOSTICS.;Color is not claimed as a feature of the mark.;medical screening services; medical diagnostic testing, monitoring and reporting services; pathology diagnostic services; prognostic analysis services; theranostic analysis services;DIAGNOSTICS;